Transfusion-transmitted Yersinia enterocolitica sepsis

Clinical Infectious Diseases

Volumn 53, Issue 6, 2011, Pages 583-591

  Guinet, Franoise ^a   Carniel, Elisabeth ^a   Leclercq, Alexandre ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ARTICLE; BACTERIUM CONTAMINATION; BLOOD TRANSFUSION REACTION; DIARRHEA; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; YERSINIA ENTEROCOLITICA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD TRANSFUSION; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; SEPSIS; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 80052189156     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir452     Document Type: Article

References (59)

1. Klein HG. How safe is blood, really? Biologicals 2010; 38:100-4.
2. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007; 131:702-7. (Pubitemid 46729528)
3. Andreu G, Caldani C, Morel C. Reduction of septic transfusion reactions related to bacteria contamination without implementing bacteria detection. ISBT Science Series 2008; 3:124-32.
4. Stainsby D, Jones H, Asher D, et al. Serious haards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20:273-82. (Pubitemid 44428107)
5. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493-9. (Pubitemid 34072672)
6. Perez P, Salmi LR, Follea G, et al. Determinants of transfusionassociated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001; 41:862-72. (Pubitemid 32642757)
7. AABB. 2007 National Blood Collection and Utilization Survey report. Available at: http://www.aabb.org/programs/biovigilance/nbcus/Pages/default. aspx. Accessed 25 July 2011.
8. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18:195-204. (Pubitemid 40170668)
9. Wagner SJ. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004; 86:157-63. (Pubitemid 38529504)
10. Centers for Disease Control and Prevention. Red blood cell transfusions contaminated with Yersinia enterocolitica-United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. JAMA 1997; 278:196-7.
11. Smego RA, Frean J, Koornhof HJ. Yersiniosis I: Microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections [Review]. Eur J Clin Microbiol Infect Dis 1999; 18:1-15. (Pubitemid 29531147)
12. Carniel E, Autenrieth I, Cornelis G, et al. Y. enterocolitica and Y. pseudotuberculosis. In: Dworkin MM, Falkow S, Rosenberg E, Schleifer K-HStackebrandt E, eds: The Prokaryotes, a handbook on the biology of bacteria, Third ed. Vol 6. Singapore: Springer, 2006.
13. Cover TL, Aber RC. Yersinia enterocolitica. New Engl J Med 1989; 321:17-24.
14. Petersen AM, Nielsen SV, Meyer D, Ganer P, Ladefoged K. Bacterial gastroenteritis among hospitalized patients in a Danish county, 1991-93. Scand J Gastroenterol 1996; 31:906-11. (Pubitemid 26313433)
15. Marks MI, Pai CH, Lafleur L, Lackman L, Hammerberg O. Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr 1980; 96:26-31. (Pubitemid 10160159)
16. Grenier B. [Yersinia enterocolitica gastroenteritis in children]. Medecine Et Maladies Infectieuses 1982; 12:685-9.
17. Bitzan M, Knapp W, Mauff G, Pulverer G. Significance of Yersinia enterocolitica isolates and antibody titers-a prospective study in patients with enteritis and healthy controls under bacteriological, serological, epidemiological and clinical aspects. Zentralbl Bakteriol Mikrobiol Hyg A 1983; 254:78-88. (Pubitemid 13105891)
18. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10:257-76. (Pubitemid 27196671)
19. Adams MR, Little CL, Easter MC. Modelling the effect of pH, acidulant and temperature on the growth rate of Yersinia enterocolitica. J Appl Bacteriol 1991; 71:65-71.
20. Mollaret HH, Thal E. Yersinia. In: Buchanan RE, Gibbons NE, eds. Bergey's manual of determinative bacteriology. 8th ed. Baltimore, MD: Williams & Wilkins Co, 1974; 330-2.
21. Burger R, Gerlich W, Gurtler L, et al. Yersinia enterocolitica. Transfus Med Hemother 2005; 32:138-46.
22. Prentice M. Transfusing Yersinia enterocolitica. Br Med J 1992; 305: 663-4.
23. Brown SE, White SE. Yersinia enterocolitica and transfusion-induced septicemia. Anesth Analg 1988; 67:415-7. (Pubitemid 18098953)
24. Stenhouse MA, Milner LV. Yersinia enterocolitica. A hazard in blood transfusion. Transfusion 1982; 22:396-8. (Pubitemid 13201177)
25. Bradley RM, Gander RM, Patel SK, Kaplan HS. Inhibitory effect of 0 degree C storage on the proliferation of Yersinia enterocolitica in donated blood. Transfusion 1997; 37:691-5. (Pubitemid 27297607)
26. Roussos A, Stambori M, Aggelis P, et al. Transfusion-mediated Yersinia enterocolitica septicemia in an adult patient with beta-thalassemia. Scand J Infect Dis 2001; 33:859-60. (Pubitemid 33069529)
27. Hogman CF, Engstrand L. Factors affecting growth of Yersinia enterocolitica in cellular blood products. Transfus Med Rev 1996; 10: 259-75. (Pubitemid 26354135)
28. Cervia JS, Wenz B, Ortolano GA. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients. Clin Infect Dis 2007; 45:1008-13. (Pubitemid 47580350)
29. Portnoy DA, Falkow S. Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. J Bacteriol 1981; 148:877-83. (Pubitemid 12178519)
30. Arduino MJ, Bland LA, Tipple MA, et al. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 1989; 27:1483-5. (Pubitemid 19170147)
31. Gibb AP, Martin KM, Davidson GA, Walker B, Murphy WG. Modeling the growth of Yersinia enterocolitica in donated blood. Transfusion 1994; 34:304-10. (Pubitemid 24136185)
32. Malbrunot C, Guiyoule A. Growth of Yersinia enterocolitica in red blood cells units. Méd Mal Infect 1990; 20:273-8. (Pubitemid 20237079)
33. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003; 112:460-7. (Pubitemid 38056327)
34. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
35. Nguyen HB, Rivers EP, Abrahamian FM, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 2006; 48:28-54.
36. Vincent JL. Sepsis definitions. Lancet 2002; 2:135.
37. Nguyen HB, Smith D. Sepsis in the 21st century: recent definitions and therapeutic advances. Am J Emerg Med 2007; 25:564-71. (Pubitemid 46818842)
38. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-77. (Pubitemid 36857845)
39. AABB. Technical manual. Brecher ME, ed., 15th ed. Available at: http://www.aabb.org. Accessed 19 April 2011.
40. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007; 370:415-26. (Pubitemid 47176657)
41. Pham JN, Bell SM, Martin L, Carniel E. The beta-lactamases and betalactam antibiotic susceptibility of Yersinia enterocolitica. J Antimicrob Chemother 2000; 46:951-7. (Pubitemid 32000605)
42. Stock I, Wiedemann B. An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother 1999; 43:37-45. (Pubitemid 29045930)
43. Stolk-Engelaar VM, Meis JF, Mulder JA, Loeffen FL, Hoogkamp-Korstanje JA. In-vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in The Netherlands from 1982-1991. J Antimicrob Chemother 1995; 36:839-43.
44. Hoogkamp-Korstanje JA. Antibiotics in Yersinia enterocolitica infections. J Antimicrob Chemother 1987; 20:123-31. (Pubitemid 17100064)
45. Noble RC. Failure of cefotaxime in the treatment of Yersinia enterocolitica sepsis despite in vitro susceptibility. Curr Ther Res 1989; 46:692-4.
46. Wilkinson TJ, Colls BM, Chambers T, Ikram RB. Blood transfusion acquired Yersinia enterocolitica sepsis: two cases. N Z Med J 1991; 104: 120.
47. Gayraud M, Scavizzi MR, Mollaret HH, Guillevin L, Hornstein MJ. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis 1993; 17:405-10. (Pubitemid 23261454)
48. Walther-Wenke G. Incidence of bacterial transmission and transfusion reactions by blood components. Clin Chem Lab Med 2008; 46:919-25.
49. Adjei AA, Kuma GK, Tettey Y, et al. Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra, Ghana. Jpn J Infect Dis 2009; 62:265-9.
50. Theakston EP, Morris AJ, Streat SJ, Baker BW, Woodfield DG. Transfusion transmitted Yersinia enterocolitica infection in New Zealand. Aust N Z J Med 1997; 27:62-7. (Pubitemid 27130180)
51. NZBlood. Haemovigilance program. Available at: http://www.nzblood.co. nz/Clinical-information/Haemovigilance-programme/Annual-haemovigilance-report. Accessed 25 July 2011.
52. Leclercq A, Martin L, Vergnes ML, et al. Fatal Yersinia enterocolitica biotype 4 serovar O: 3 sepsis after red blood cell transfusion. Transfusion 2005; 45:814-8. (Pubitemid 40656398)
53. Afssaps. French hemovigilance site. Available at: http://www.afssaps.fr/ Activites/Hemovigilance/Hemovigilance/. Accessed 25 July 2011.
54. Reesink HW, Panzer S, Gonzalez CA, et al. Haemovigilance for the optimal use of blood products in the hospital. Vox Sang 2010; 99: 1-16.
55. "National menus" section of the International Haemovigilance Network Web-site. Available at: http://www.ihn-org.net. Accessed 25 July 2011.
56. Prinoth O. Systems for monitoring transfusion risk. Blood Transfus 2008; 6:86-92. (Pubitemid 352025964)
57. Funk MB, Gunay S, Lohmann A, Henseler O, Keller-Stanislawski B. Evaluation of measures aimed to reduce serious adverse transfusion reactions (hemovigilance data from 1997 to 2008). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53:347-56.
58. Funk MB, Günay S, Lohmann A, Witzenhausen C, Henseler O. Haemovigilance report 1997-2008: assessment of reports of serious adverse transfusion reactions. Available at: http://www.pei.de/cln-092/SharedDocs/ Downloads/fachkreise/haemovigilanz/publikationen/haemovigilance-report-1997- 2008.html. Accessed 25 July 2011.
59. Momose S, Taira R, Muraoka M, et al. Haemovigilance data for five years by Japanese red cross blood service: transfusion-related adverse reactions and infections from 2004 to 2008 (Meeting abstract). Vox Sang 2009; 97:165.